Podcasts about Medical cannabis

Host Dr Russell Thackeray interviews Dale Atkinson from near Reading, a former finance compliance consultant who now works as a patient advocate, audits companies for “patient trust leaks,” sells adjunct wellness modalities, and writes.Dale recounts that in 2024 his partner was diagnosed with small cell lung cancer and surgically cured, then he was found to have a large esophageal tumour and later told he had terminal, metastatic cancer (T4b N3 M1) with 11.5 months to live, after years of GP visits for GI symptoms and a long wait for a “routine” endoscopy.He pursued chemotherapy and immunotherapy alongside extensive research, next-generation sequencing, off-label medications, nutrition/naturopathic support, and modalities such as hyperbaric oxygen, high-dose vitamin C protocols, ketosis/fasting, and medical cannabis, while warning against social-media “snake oil.”He reports no visible signs of disease, has made major lifestyle changes to reduce stress, and is launching a charity, Beyond the Standard, to push NHS change; he emphasises self-advocacy.00:00 Welcome and Introductions00:28 From Finance to Advocacy01:34 A Shocking Cancer Cascade03:38 Years of Missed Symptoms06:09 Turning Anger Into Research09:24 Snake Oil and Red Herrings11:57 Chemo Immuno and Realistic Goals13:17 Next-Gen Sequencing Explained16:41 Integrative Care vs NHS Pathway18:30 Lifestyle Overhaul After Diagnosis20:03 Where to Start Without Rabbit Holes20:41 Avoid Social Media Gurus21:26 Find Credible Integrative Experts22:08 Vetting Doctors and Directories24:27 Biohacking Hype and Supplement Scams25:30 Bloodwork Guided Supplementation26:31 Ketosis and Fasting Strategy28:23 Medical Cannabis for Symptoms31:31 Access and NHS Change Efforts33:51 Prognosis and Staying on Protocol34:37 Hyperbaric Oxygen and Red Light36:43 Self Advocacy and Final TakeawaysYou can contact us at info@qedod.comResources can be found online or link to our website https://resilienceunravelled.com

Survivor: Africa winner Ethan Zohn joins Rev. Dr. Robin Swan for a powerful conversation about cancer, cannabis, resilience and finding purpose after a life-changing diagnosis. Ethan's life had already taken him from professional soccer to winning CBS's Survivor: Africa when, at age 35, he was diagnosed with a rare form of Hodgkin lymphoma. What followed was an intense medical journey involving chemotherapy, radiation, clinical trials and two stem cell transplants. In this episode, Ethan shares his personal experience with medical cannabis and how it became part of the way he managed some of the physical and emotional challenges surrounding cancer treatment and recovery, including nausea, pain, sleep difficulties and anxiety. Ethan and Robin also discuss the changing conversation around cannabis in professional sports, the importance of responsible education and advocacy, and why patients need honest information when making decisions about their health. The conversation goes far beyond cancer. Ethan explains how surviving a life-threatening illness reshaped his sense of purpose and strengthened his commitment to helping others. He discusses Grassroot Soccer, the nonprofit organization he co-founded that uses the power of soccer to improve the health and lives of young people around the world, as well as Kicking Back, his High Times series exploring the intersection of soccer, cannabis and community. In this episode: Ethan's journey from professional soccer to winning Survivor: Africa Being diagnosed with Hodgkin lymphoma at age 35 Chemotherapy, radiation, clinical trials and two stem cell transplants Ethan's personal experience using cannabis during cancer treatment and recovery Cannabis for nausea, pain, sleep and anxiety The emotional and psychological challenges of cancer survivorship How attitudes toward cannabis are changing in professional sports Cannabis education, responsible use and patient advocacy Turning personal crisis into purpose The story and mission behind Grassroot Soccer Ethan's Kicking Back series with High Times Soccer, cannabis and community Using lived experience to help others facing serious illness Learn more about Ethan Zohn Ethan Zohn:https://ethanzohn.com Grassroot Soccer:https://grassrootsoccer.org Cannabis Health Radio Visit:https://cannabishealthradio.com If this conversation could help someone you know, please share the episode. Subscribe to Cannabis Health Radio for more conversations with patients, advocates, researchers and others exploring cannabis, health and healing. Connect with Cannabis Health RadioVisit us at CannabisHealthRadio.comExplore products and resources from Swan ApothecaryFollow Cannabis Health Radio on Facebook and InstagramImportant DisclaimerThe views and opinions expressed by guests on Cannabis Health Radio (CHR) are their own and do not necessarily reflect those of CHR, its hosts, producers, affiliates, or sponsors. CHR is not responsible for statements or opinions expressed by its guests.Nothing presented in this episode constitutes medical advice, diagnosis, treatment, or a recommendation regarding what you should do. This content is provided for informational and entertainment purposes only. Always consult a qualified healthcare professional regarding your health, medical conditions, medications, or treatment decisions. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Macca and Kenny are joined by Fiona Patten — Former Victorian MP &a Incoming CEO, Medical Cannabis Council and Robbie Swanks live in the studio Before she was a Victorian MP, Fiona Patten spent years campaigning on some of the issues politicians were often most uncomfortable talking about — sex, censorship, reproductive rights and personal freedom. She went on to help establish the Australian Sex Party with her partner, Robbie Swan, and eventually took that campaign for law reform into the Victorian Parliament. Now, as she prepares to move to Canberra to become CEO of the Medical Cannabis Council, another chapter of that story is being told in Robbie Swan’s new book, A Funny Thing Happened on the Way to the Sex Party. It’s part memoir, part social history — and a look at the strange intersection of the sex industry, politics, censorship and activism in Australia. The post Sat, 8th August, 2026: Fiona Patten, Former Victorian MP; Incoming CEO, Medical Cannabis Council appeared first on Saturday Magazine.

What does it take to make a cannabis facility audit-ready for EU GMP standards? Explore pharmaceutical-grade infrastructure, cleanroom requirements, inspection expectations, and the ongoing work required to maintain compliance in Europe's medical cannabis sector. Learn more at https://hempirelabs.com Hempire Labs S.L. City: Sotogrande Address: C.C., Mar y Sol Local 3.9 Website: https://hempirelabs.com

On the August 5 edition: A look at how better guardrails could ensure police use Flock cameras responsibly; Georgia's major party gubernatorial candidates make their pitch to the business community; And the Atlanta City Council wants the Mayor's office to sign off on a city-wide heat plan. 

What happens when the medical cannabis system veterans depend on becomes more expensive, less accessible and increasingly disconnected from their needs?In Part 2 of this candid conversation, veterans Rob Sipes and Natalie Forcier—joined by cannabis nurse Kala Knudslien—explore how education, professional guidance and intentional cannabis use can help veterans manage PTSD-related sleep disturbances, chronic pain and inflammation.Rob shares how he incorporates CBD, THC edibles and topical cannabis into a carefully structured routine while living with serious medical challenges, including hemodialysis, neuropathy, two lung conditions, oxygen therapy and a complex medication regimen. His experience reinforces one of the episode's most important messages: veterans using medical cannabis, especially alongside multiple prescription medications, benefit from individualized assessment, ongoing follow-up and knowledgeable healthcare support.The conversation also examines Veterans Affairs Canada cannabis reimbursement limits, the potential relationship between medical cannabis and polypharmacy, and the widening gap between Canada's medical and recreational cannabis markets. As recreational producers increasingly prioritize high-THC products, Kirk and Trevor ask whether veterans and other medical patients are losing access to consistent CBD-rich formulations, balanced cannabinoid products and the clinical guidance needed to use them safely and effectively.This episode is a thoughtful, human look at medical cannabis for veterans—and a warning about what could be lost if Canada's medical cannabis system continues to shrink.Listen now to hear Rob and Natalie's stories and learn why cannabis education, professional support and reliable access remain essential parts of veteran care.Additional Music:Desiree Dorion desireedorion.comMarc Clement - FacebookTranscripts, papers and so much more at: reefermed.ca

This week on High on Home Grown, we bring you another round-up of the biggest cannabis stories from the UK and around the world, covering crime, medical cannabis, regulation, and the continuing evolution of legal markets. Macky: Essex resident sentenced for importing 24 kilos of cannabis concealed in his vehicle  Thai cannabis smuggler jailed for 12 months - National Crime Agency Smee: NHS Trust Approves UK-First Inpatient Medical Cannabis Policy · CannabisHealth Guernsey deputy calls for cannabis to be taxed 'like alcohol' - BBC News Dr.Margaret: Report: Illegal cannabis diversion from Canada a growing problem in Europe  Billy: Two Strain review/grinder report This week we discuss two separate cannabis smuggling cases, examining the risks people continue to take despite increasingly sophisticated border enforcement. We also look at a landmark decision by an NHS Trust to approve the UK's first inpatient medical cannabis policy, a significant step forward for patient access within the healthcare system. Smee also brings us a story from Guernsey, where calls are growing for cannabis to be regulated and taxed in a similar way to alcohol, echoing many of the arguments we've been making on the show for years. Dr. Margaret explores a new report warning that cannabis legally produced in Canada is increasingly finding its way onto Europe's illicit market, raising fresh questions about regulation and international trade. Billy rounds off the episode with two more strain reviews, sharing his thoughts on the latest flower he's been trying. Another packed episode full of cannabis news, medical developments, policy discussions, and honest opinions from the High on Home Grown panel.

Medical cannabis sits in a crowded space of strong claims, real risks, and uneven regulation. Dr. Peter Grinspoon joins Mike Vera for an honest conversation about what cannabis may help, what can harm, and what remains unknown, from rescheduling and unregulated hemp-derived products to dependence, CBD labels, sleep, and aging.A note before you listen: this conversation covers cannabis use and addiction. It is shared for educational purposes only and is not medical advice. If you are struggling or in crisis, support is available 24/7: in the US, call or text 988 (Suicide and Crisis Lifeline), or text HOME to 741741 (Crisis Text Line). Outside the US, contact your local emergency services or crisis line. If you or someone you know is struggling with substance use, SAMHSA's National Helpline is 1-800-662-HELP (4357).

“I saw the light, and the light won.” Born with cataracts and living with visual impairment for most of her life, Sage Amdahl never imagined that one unexpected experience would completely change the direction of her life. In this milestone 500th episode of Cannabis Health Radio, Sage shares her remarkable journey of discovering cannabis, learning to trust her own body, and finding healing where traditional approaches had fallen short. What began as a personal path toward wellness soon became something much bigger. Combining her passion for cannabis with her lifelong love of cooking, Sage created a business focused on crafting delicious infused treats designed with both care and purpose. Episode 500 celebrates not only an important milestone for Cannabis Health Radio, but also the power of resilience, curiosity, and following a path that can change lives. Connect with Sage: https://www.facebook.com/sage.amdahl.3 https://www.facebook.com/420sageadvice Cannabis Health Radio shares real stories from patients, caregivers, healthcare professionals, researchers and advocates exploring the therapeutic potential of cannabis and other plant medicines. Visit our website: CannabisHealthRadio.comDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Why do some people with hEDS or HSD report meaningful relief with medical cannabis, while others feel worse, notice no benefit, or experience side effects? And what might these varied responses teach us about pain, the autonomic nervous system, gut function, and nervous system sensitization? In this episode, host Dr. Linda Bluestein, the Hypermobility MD, is joined by Professor David Nutt, a neuropsychopharmacologist at Imperial College London, and Lucy Stafford, a PhD researcher in clinical neuroscience with lived experience of hypermobile Ehlers-Danlos syndrome. This is not a hype episode, a recommendation to use cannabis, or medical advice. Instead, it is a careful, curiosity-driven conversation about what is known, what is still emerging, and what remains uncertain about medical cannabis in hEDS and HSD. Lucy shares her experience of severe illness, high-dose opioid treatment, a feeding tube, repeated ICU stays, and eventually coming off opioids, an experience that helped shape her path into cannabinoid research. Professor Nutt explains the discovery of the endocannabinoid system and why this system may be relevant to pain processing, stress responses, autonomic regulation, immune signaling, and gut function. Together, they explore how cannabinoids may influence a sensitized nervous system, why responses vary so widely, and why medically complex patients need individualized guidance rather than shame, dismissal, or unsupported promises. The conversation covers many of the practical questions patients often ask, including the difference between CBD and THC, full-spectrum products, terpenes and the entourage effect, routes of administration, absorption differences, and the importance of a cautious “start low, go slow” approach when cannabis is being considered under appropriate medical supervision. They also address important safety considerations, including contraindications, drug interactions, psychiatric risk, impairment, dependence, and why cannabis is not appropriate for everyone. The episode closes with a broader discussion of stigma, the emerging science of psychedelics for chronic pain, and the human and financial costs of undertreated complex illness. The Bendy Bodies podcast is for educational purposes only and is not a substitute for personalized medical advice. Laws, product quality, dosing, and individual risks vary, so patients should consult a qualified healthcare professional before using cannabis or changing any treatment plan. Takeaways: The endocannabinoid system is an important regulatory system involved in pain processing, stress responses, immune signaling, gut function, and nervous system homeostasis, yet it receives relatively little attention in medical and neuroscience training. Cannabinoids do not work like opioids. Rather than simply “blocking” pain, they may influence pain modulation, nervous system sensitization, autonomic tone, and gut motility, though much remains to be studied specifically in hEDS and HSD. CBD and THC have different effects, benefits, and risks. CBD may reduce some unwanted THC effects for certain people, but responses vary, and dosing should be individualized. A cautious “start low, go slow” approach is especially important for medically complex patients, particularly those with dysautonomia, medication sensitivity, MCAS-like symptoms, anxiety, or multiple medications. Individual responses to cannabis vary widely. Differences in absorption, metabolism, product composition, route of administration, and underlying physiology may help explain why one person improves while another worsens or notices no effect. Cannabis is not right for everyone. Extra caution is warranted for people with a history of psychosis, paranoia, substance use disorder, significant cognitive impairment, fall risk, pregnancy, or medications metabolized through overlapping liver pathways. Patients deserve balanced information: neither stigma and dismissal nor exaggerated promises. The goal is thoughtful, evidence-informed, individualized decision-making. Go http://www.AquaTru.com now for 20% off (your purifier) using promo code BENDY. Head to http://www.cozyearth.com and use my code BENDY for an exclusive 20% off. Want more Professor Dave Nutt & Lucy Stafford? X / Twitter link. Profdavidnutt@twitter.com & @lucystaffie BleuSky:profdavidnutt@bluesky.com Instagram: @lustaffordphd, @drugscienceuk, @Drug_Science & @EmbodiedNeuro Want more Dr. Linda Bluestein, MD? Website: https://www.hypermobilitymd.com/ YouTube: https://www.youtube.com/@bendybodiespodcast Instagram: ⁠⁠⁠⁠https://www.instagram.com/hypermobilitymd/⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠https://www.facebook.com/BendyBodiesPodcast⁠⁠⁠⁠ X: ⁠⁠⁠⁠https://twitter.com/BluesteinLinda⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠https://www.linkedin.com/in/hypermobilitymd/⁠⁠⁠⁠ Newsletter: ⁠⁠⁠⁠https://hypermobilitymd.substack.com/ Shop my Amazon store ⁠⁠⁠ https://www.amazon.com/shop/hypermobilitymd Dr. Bluestein's Recommended Herbs, Supplements and Care Necessities: https://us.fullscript.com/welcome/hypermobilitymd/store-start Want to learn more about the UVA EDS Center? For Appointments and Questions: RUVAEDSCenter@uvahealth.org UVA EDS: https://www.uvahealth.com/healthy-practice/advancing-care-through-ehlers-danlos-clinic UVA EDS FAQ: https://www.uvahealth.com/support/eds/faq UVA Pediatric Integrative Medicine: https://childrens.uvahealth.com/specialties/integrative-health Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at ⁠⁠https://www.bendybodiespodcast.com/⁠⁠. YOUR bendy body is our highest priority!⁠⁠ Learn more about Human Content at ⁠⁠⁠http://www.human-content.com⁠⁠⁠ Podcast Advertising/Business Inquiries: ⁠⁠⁠sales@human-content.com⁠⁠⁠ Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Learn more about your ad choices. Visit megaphone.fm/adchoices

Why do some people with hEDS or HSD report meaningful relief with medical cannabis, while others feel worse, notice no benefit, or experience side effects? And what might these varied responses teach us about pain, the autonomic nervous system, gut function, and nervous system sensitization? In this episode, host Dr. Linda Bluestein, the Hypermobility MD, is joined by Professor David Nutt, a neuropsychopharmacologist at Imperial College London, and Lucy Stafford, a PhD researcher in clinical neuroscience with lived experience of hypermobile Ehlers-Danlos syndrome. This is not a hype episode, a recommendation to use cannabis, or medical advice. Instead, it is a careful, curiosity-driven conversation about what is known, what is still emerging, and what remains uncertain about medical cannabis in hEDS and HSD. Lucy shares her experience of severe illness, high-dose opioid treatment, a feeding tube, repeated ICU stays, and eventually coming off opioids, an experience that helped shape her path into cannabinoid research. Professor Nutt explains the discovery of the endocannabinoid system and why this system may be relevant to pain processing, stress responses, autonomic regulation, immune signaling, and gut function. Together, they explore how cannabinoids may influence a sensitized nervous system, why responses vary so widely, and why medically complex patients need individualized guidance rather than shame, dismissal, or unsupported promises. The conversation covers many of the practical questions patients often ask, including the difference between CBD and THC, full-spectrum products, terpenes and the entourage effect, routes of administration, absorption differences, and the importance of a cautious “start low, go slow” approach when cannabis is being considered under appropriate medical supervision. They also address important safety considerations, including contraindications, drug interactions, psychiatric risk, impairment, dependence, and why cannabis is not appropriate for everyone. The episode closes with a broader discussion of stigma, the emerging science of psychedelics for chronic pain, and the human and financial costs of undertreated complex illness. The Bendy Bodies podcast is for educational purposes only and is not a substitute for personalized medical advice. Laws, product quality, dosing, and individual risks vary, so patients should consult a qualified healthcare professional before using cannabis or changing any treatment plan. Takeaways: The endocannabinoid system is an important regulatory system involved in pain processing, stress responses, immune signaling, gut function, and nervous system homeostasis, yet it receives relatively little attention in medical and neuroscience training. Cannabinoids do not work like opioids. Rather than simply “blocking” pain, they may influence pain modulation, nervous system sensitization, autonomic tone, and gut motility, though much remains to be studied specifically in hEDS and HSD. CBD and THC have different effects, benefits, and risks. CBD may reduce some unwanted THC effects for certain people, but responses vary, and dosing should be individualized. A cautious “start low, go slow” approach is especially important for medically complex patients, particularly those with dysautonomia, medication sensitivity, MCAS-like symptoms, anxiety, or multiple medications. Individual responses to cannabis vary widely. Differences in absorption, metabolism, product composition, route of administration, and underlying physiology may help explain why one person improves while another worsens or notices no effect. Cannabis is not right for everyone. Extra caution is warranted for people with a history of psychosis, paranoia, substance use disorder, significant cognitive impairment, fall risk, pregnancy, or medications metabolized through overlapping liver pathways. Patients deserve balanced information: neither stigma and dismissal nor exaggerated promises. The goal is thoughtful, evidence-informed, individualized decision-making. Go http://www.AquaTru.com now for 20% off (your purifier) using promo code BENDY. Head to http://www.cozyearth.com and use my code BENDY for an exclusive 20% off. Want more Professor Dave Nutt & Lucy Stafford? X / Twitter link. Profdavidnutt@twitter.com & @lucystaffie BleuSky:profdavidnutt@bluesky.com Instagram: @lustaffordphd, @drugscienceuk, @Drug_Science & @EmbodiedNeuro Want more Dr. Linda Bluestein, MD? Website: https://www.hypermobilitymd.com/ YouTube: https://www.youtube.com/@bendybodiespodcast Instagram: ⁠⁠⁠⁠https://www.instagram.com/hypermobilitymd/⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠https://www.facebook.com/BendyBodiesPodcast⁠⁠⁠⁠ X: ⁠⁠⁠⁠https://twitter.com/BluesteinLinda⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠https://www.linkedin.com/in/hypermobilitymd/⁠⁠⁠⁠ Newsletter: ⁠⁠⁠⁠https://hypermobilitymd.substack.com/ Shop my Amazon store ⁠⁠⁠ https://www.amazon.com/shop/hypermobilitymd Dr. Bluestein's Recommended Herbs, Supplements and Care Necessities: https://us.fullscript.com/welcome/hypermobilitymd/store-start Want to learn more about the UVA EDS Center? For Appointments and Questions: RUVAEDSCenter@uvahealth.org UVA EDS: https://www.uvahealth.com/healthy-practice/advancing-care-through-ehlers-danlos-clinic UVA EDS FAQ: https://www.uvahealth.com/support/eds/faq UVA Pediatric Integrative Medicine: https://childrens.uvahealth.com/specialties/integrative-health Thank YOU so much for tuning in. We hope you found this episode informative, inspiring, useful, validating, and enjoyable. Join us on the next episode for YOUR time to level up your knowledge about hypermobility disorders and the people who have them. Join YOUR Bendy Bodies community at ⁠⁠https://www.bendybodiespodcast.com/⁠⁠. YOUR bendy body is our highest priority!⁠⁠ Learn more about Human Content at ⁠⁠⁠http://www.human-content.com⁠⁠⁠ Podcast Advertising/Business Inquiries: ⁠⁠⁠sales@human-content.com⁠⁠⁠ Part of the Human Content Podcast Network FTC: This video is not sponsored. Links are commissionable, meaning I may earn commission from purchases made through links Learn more about your ad choices. Visit megaphone.fm/adchoices

Stephen couldn't make it to the show so today I covered various subjects with the live chat audience: Orgone Generators, Canada/US Relations, My 2 Books About ET Contact, Medical Cannabis and much more. Thank you for leaving me a comment, like my videos, and do share my content with your friends!YouTube Link: https://youtu.be/yVwq4xntn7MBGcast & Esoteric Caravan Links:https://www.youtube.com/@EsotericCaravanRumble: https://rumble.com/user/BGcast?fbclid=IwZXh0bgNhZW0CMTAAAR158Yi7iXDkxZ2_vMCHUWqcDMpedtnngVIfKM3SNIW0znLyNu9L_KXd-90_aem_AU4jZs7LKeD467GErKy7FvwTSh77meXHiiTWZiJasi-7lCqBHipZg-lfFaKEgAbXQxjQauaBh-9NiL0aW8N99YIjApple: https://podcasts.apple.com/us/podcast/bgcast/id1681871376Karen Holton's Links:• Link Tree: https://linktr.ee/karenholtontv • Download my exclusive audio content found only on SPREAKER, Spotify, Apple, Podbean, iHeart, Goodpods and more – https://www.spreaker.com/show/quantum-guides-show-with-karen-holton• TRANSDIMENSIONAL: Meet the New Neighbours by Karen Holton (paperback & Kindle now available from Amazon Worldwide) US: https://www.amazon.com/dp/1069173509?ref_=pe_93986420_774957520& Canada: https://www.amazon.ca/TRANSDIMENSIONAL-Neighbours-Ms-Karen-Holton/dp/1069173509 • Buy Me A Coffee: https://buymeacoffee.com/karenholtontv • Join My YouTube Channel to receive my perks! https://www.youtube.com/@KarenHoltonTV/join• Website: https://www.karenholtonhealthcoach.com/   • Channels:Censored Content: https://www.youtube.com/@KarenHoltonTV• Uncensored Content: Odysee: https://odysee.com/@KarenHoltonTV - Rumble: https://rumble.com/KarenHoltonTV - X (Twitter): https://x.com/KarenHoltonTV and Telegram: https://t.me/KarenHoltonTV• Instagram: https://www.instagram.com/karenholtontv • Facebook: https://www.facebook.com/karen.holton3  Please follow me on Odysee, X, Telegram & Rumble and help me to grow my channels!The Quantum Guides Show, and the Aliens & Angels Podcast are now part of the Forbidden Knowledge News Network! https://forbiddenknowledge.news/Other valuable content from Karen Holton:Quantum Health Transformation V.3.0 - a free, no strings attached, 9 Step online, lifestyle course to give you the tips and resources you need to thrive! By following my own channeled advice, I made my dreams come true! Whether you are in the awakening process, or simply want more out of life, this course is for you.Complete Quantum Health Transformation V3.0 Playlist on YouTube: https://www.youtube.com/watch?v=qwSmOYvGXBA&list=PLe1pNMTCSTLlzyU9vc_SmK4zs4_JCcpa1&pp=gAQBiAQB - or watch the Quantum Health Transformation V.3.0 program on Karen's website:https://www.karenholtonhealthcoach.com/quantum-health-transformation-free-online-course/ Complete Quantum Guides Show 2024 Playlist on YouTube (Episodes 148+) - Interviews with Awakened Masters! Their quantum work will inspire you! This podcast is ideally suited to the newly awakened, and for those who wish to learn about the greater reality which lies outside of the mainstream construct. https://www.youtube.com/watch?v=yaA4TlBjcvM&list=PLe1pNMTCSTLkNBkKxasRct_8h7STDzaqv&index=1Aliens & Angels Podcast: Featuring real-life people with real-life experiences. Complete playlist: https://www.youtube.com/watch?v=sU1NHGAVG28&list=PLe1pNMTCSTLk4saG-kQHgWqx-QQ7BtMAv&index=1Karen's Website: https://www.karenholtonhealthcoach.com  Karen's Free Resources - https://www.karenholtonhealthcoach.com/free-resources/  Support Karen Holton TV:TRANSDIMENSIONAL: Meet the New Neighbours by Karen Holton (paperback & Kindle now available from Amazon Worldwide) US: https://www.amazon.com/dp/1069173509?ref_=pe_93986420_774957520 & Canada: https://www.amazon.ca/TRANSDIMENSIONAL-Neighbours-Ms-Karen-Holton/dp/1069173509Buy Me A Coffee - https://buymeacoffee.com/karenholtontv Join My YouTube Channel to receive my perks! https://www.youtube.com/@KarenHoltonTV/joinZen Domes Orgonite - https://www.karenholtonhealthcoach.com/product-category/zen-domes-orgonite/  Comfort Crystals - https://www.karenholtonhealthcoach.com/product-category/comfort-crystals/  Services & Support - https://www.karenholtonhealthcoach.com/product-category/services/  PDF Downloads - https://www.karenholtonhealthcoach.com/product-category/downloads/ Thank you for subscribing, liking, commenting and sharing!

What happens when veterans turn to medical cannabis after conventional treatments leave them exhausted, foggy or still unable to sleep?Former Canadian Armed Forces medics Natalie Forcier and Rob Sipes share how PTSD, chronic pain, anxiety, nightmares and service-related injuries shaped their journeys with medicinal cannabis.Together with cannabis nurse Kala Knudslien, Natalie and Rob discuss administration routes like cannabis gummies, oils, creams and other non-inhaled products. Then they get into how various cannabinoids like CBD, CBN, CBG and lower-dose THC, cannabis tolerance effect their individualized care. Natalie also explains how non-intoxicating cannabis topicals can help cautious veterans and first responders reconsider medical cannabis as a pain-management option.The conversation also examines Veterans Affairs Canada cannabis coverage, including the three-gram daily limit, reimbursement reductions and the widening gap between recreational and medical cannabis prices. It raises important questions about access, veteran advocacy and whether commercial interests are influencing Canada's medical cannabis system.Listen now to hear two veterans speak candidly about PTSD, sleep, pain, cannabis education and the struggle to access the care and benefits they earned through service. Additional Music:Desiree Dorion desireedorion.comMarc Clement - FacebookTranscripts, papers and so much more at: reefermed.ca

On today's show, we hear about a new study by UAMS that examines the pattern of purchasing medical cannabis throughout pregnancy. We also learn how the Arkansas Folk and Traditional Arts works to make sure important parts of the state thrive. Plus, we explore new plants and new spaces at the Jones Center.

Medical cannabis producers face costly licensing delays from overlooked GMP standards in lab design. Cleanroom engineering failures, poor ventilation, and documentation gaps are the pharmaceutical-grade pitfalls that derail facilities — and proper planning from day one prevents them. To learn more, visit https://hempirelabs.com/ Hempire Labs S.L. City: Sotogrande Address: C.C., Mar y Sol Local 3.9 Website: https://hempirelabs.com

Here are the news stories from this weeks show: Macky: Who Really Benefits from Britain's Medical Cannabis System?  Smee: Police officer's sense of smell sniffs out force's 'biggest ever cannabis farm' in Mansfield | ITV News Calendar  Dr.Margaret: Cracking open a can of cannabis — America's new pastime - Canadian Affairs  Billy: Strain Review - Greyscales - Medical cannabis quality control. John: Marijuana's 'Entourage Effect' Varies By Terpene And Cannabinoid Receptor, New Study Suggests This week we take a closer look at Britain's medical cannabis system, asking who is really benefiting from the current model and whether patients are getting the access and affordability they deserve. We also discuss an unusual story from Nottinghamshire, where a police officer's sense of smell reportedly led to the discovery of the force's largest-ever cannabis grow. Dr. Margaret explores the rapidly growing popularity of cannabis-infused beverages in North America and why many consumers are choosing them as an alternative to alcohol. Billy returns with another honest review of UK medical cannabis, examining the quality of the Greyscales flower and whether standards continue to improve. Finally, John dives into new research on the entourage effect, revealing how different terpenes and cannabinoid receptors may influence the way cannabis works in the body. Another packed episode full of cannabis news, science, medicine, and the stories shaping the industry across the globe.

In this episode, we sit down with Stefan Adomeit, Managing Director of Remexian Pharma, one of Europe's leading medical cannabis distributors and Germany's largest importer by volume.Stefan shares the remarkable journey behind building Remexian into a market leader through a disciplined, profitable business model, despite operating with a remarkably lean team and without the excessive spending that defined much of the early cannabis industry.We discuss:

What happens when medical cannabis is legal—but medical patients are still left without meaningful guidance?Part 2 of Kirk's conversation with Ted Smith of the Victoria Cannabis Buyers Club explores the widening gap between legalization, Health Canada's medical cannabis framework, and the real-world needs of patients. It seems many Canadians using cannabis for medical reasons are now being pushed toward recreational stores, where staff are not equipped to discuss drug interactions, dosing, high-potency extracts, suppositories, cancer care, or complex chronic conditions.Kirk, Trevor, and Ted dig into why compassion clubs still matter after legalization, how cannabis coaches, and community-based educators are filling gaps left by doctors, nurses, pharmacists, and regulators, and why “legal cannabis” is not the same as “medical cannabis.” The conversation also touches on RSO, cytochrome P450 drug interactions, CBD and prescription medications, harm reduction, stigma, raids on the Victoria Cannabis Buyers Club, and Ted's long-term vision for integrated cannabis-focused palliative care.Listen now to understand why medical cannabis advocacy did not end with legalization—and why patients, healthcare professionals, and policymakers still need to pay attention.The Victoria Cannabis Buyers Club - websiteTed Smith - LinkedInAdditional Music:Desiree Dorion desireedorion.comMarc Clement - FacebookTranscripts, papers and so much more at: reefermed.ca

This week on High on Home Grown, we cover some of the biggest cannabis and drug policy stories from around the world, along with a brutally honest review of UK medical cannabis. Macky: Sent in by Lob Barmey: Irish committee recommends decriminalisation of all drug possession for personal use - BBC News  Smee: Father says NHS approval of cannabis based-medicine for epilepsy is 'nothing special' | LBC Dr.Margaret:  DEA's youMarijuana Rescheduling Hearing Includes The Wrong Voices (Op-Ed)  Billy:  Will be doing a news report on ‘Medical Cannabis'  and a strain review with a rant about how fucking shit it is. (possible foul language) Big Narstie Medical AM T23 Ammy Medical Cannabis Flower •

This episode explains the recent federal changes — including the DOJ rescheduling state-authorized medical marijuana and the ATF's proposed edits to Form 4473 — and how those changes affect medical cannabis patients and gun owners in North Dakota. It breaks down the difference between state medical programs and recreational use, highlights cross-border risks, who is affected, and practical next steps like reading the draft, noting the public comment deadline, and consulting qualified professionals. #NDMedCard #NDMedCardPodcast #NorthDakota #NorthDakotaMedicalCannabis #MedicalCannabis #MedicalMarijuana #CannabisEducation #CannabisNews #PatientRights #KnowTheLaw

What happens when a cannabis compassion club gets raided again despite previous Supreme Court decisions on their side, fervent public support, and years after cannabis legalization?Kirk visits Ted Smith at the Victoria Cannabis Buyers Club (VCBC) just days after its latest raid. Ted discusses ongoing legal challenges, compassionate access, Rick Simpson Oil (RSO), cannabis harm reduction, pharmacist-led patient screening, CBD drug interactions, and the future of medical cannabis in Canada.This is a thought-provoking conversation about patient care, cannabis policy, and why some Canadians still struggle to access the products they need.Listen now to learn how advocacy, healthcare, and cannabis policy continue to collide in post-legalization Canada.The Victoria Cannabis Buyers Club - websiteTed Smith - LinkedInAdditional Music:Desiree Dorion desireedorion.comMarc Clement - FacebookTranscripts, papers and so much more at: reefermed.ca

Host Paul introduces the differences between North Dakota's medical cannabis program and nearby recreational markets, explaining patient-focused care, privacy, cost benefits, and the legal risks of crossing state lines. He also previews a major federal change to ATF Form 4473 and how it may affect veterans and gun owners. Visit ndmedcard.com for straightforward information about qualifying conditions, providers, and how the program works, and tune in to future episodes for deeper legal and expert interviews. #NDMedCard #NDMedCardPodcast #NorthDakota #NorthDakotaMedicalCannabis #MedicalCannabis #MedicalMarijuana #CannabisEducation #CannabisNews #PatientRights #KnowTheLaw

This week I'm joined by Dr. Simon Erridge, medical doctor, UCL researcher, and one of the UK's leading voices in medical cannabis. We delve into how Medical Cannabis really impacts our bodies and how people are actually accessing the drug?My book ‘Healthy Shouldn't Be This Hard': ⁠https://www.amazon.co.uk/Healthy-Shouldnt-Be-This-Hard-ebook/dp/B0G1DHNRV5⁠This episode is sponsored by:DIOME: Rest deeper. Stay grounded. Rested is available now and Grounded lands later this month. 

Two mothers fought British bureaucracy to obtain lifesaving cannabis medicines for their children. But most patients are having to go private – at huge cost Written and read by Kojo Koram. Help support our independent journalism at theguardian.com/longreadpod

Can full-spectrum cannabis work better than isolates — even if it tastes worse?In Part 2 with Seann Poli of JAN Rx, Trevor explores CBG, CBC, acidic cannabinoids, the entourage effect, veteran cannabis care, and why cannabis companies are increasingly filling healthcare roles traditionally held by pharmacists and nurses. Plus: a new “rocket fuel” cannabinoid blend, hormone-focused cannabis products, and the future of medical cannabis guidance in Canada.Listen now.Seann Poli - LinkedInJANrx -WebsiteTranscripts, papers and so much more at: reefermed.ca

Here are the stories we cover in this weeks show: Macky:  Warnings the medicinal cannabis industry could turn deadly without tougher regulation | ITV News Channel  Smee: Police defend decision to dismantle another Leicester cannabis grow | Leicestershire Live  Dr.Margaret: Marijuana Can Play A Role In Combating Obesity, Contrary To Stereotypes About Lazy Stoners With The Munchies, New Federally Funded Study Suggests Billy: UK Medical Cannabis Imports Hit 30 Tonnes as Canadian Producers Bypass European Processors  John: Federal Judge Dismisses Anti-Marijuana Groups' Lawsuit Challenging Medicare Hemp Coverage Program We have some propaganda as usual, where it is claimed medical cannabis can turn deadly if its not properly regulated! Ridiculous! Also, we see evidence that cannabis can help reduce obesity, regardless of the stereotypical Munches it gives us. Police in the UK defend their actions of taking down a cannabis grow, amongst backlash from social media messages. The UK has imported over 30 tonnes of cannabis form Canada! And some USA cannabis company is making it harder for new people to join the industry!  Lots going on in the world of cannabis news! I hope you enjoy the episode! 

  Purpose of the episode: Jeff Krajnak, a combat veteran, shares how medical cannabis helped him reduce opioid dependency and how THC metabolite laws led to criminal charges despite no impairment. Military service with the Navy Seabees and SEAL teams in Iraq and Afghanistan left Jeff with severe PTSD, fibromyalgia, and ankylosing spondylitis, resulting in a medical discharge in December 2013. Post-discharge, Jeff was consuming 11 opioid and psychiatric pills daily, drinking a bottle of vodka a day, and described himself as detached, suicidal, and hospitalized in a psych ward for eight days. Switching to medical cannabis — an indica strain for sleep and a CBD cream for pain — allowed Jeff to reduce from 11 pills to just one, and eventually quit opioids entirely. A 2017 car accident occurred when another driver ran a red light; Jeff and his son were uninjured, he cooperated with police, passed three field sobriety tests, and showed no signs of impairment. Despite every officer on scene testifying he was not impaired, Jeff was arrested 32 days later by a SWAT team due to THC metabolites in his blood — 4 nanograms active, 40 nanograms metabolite — exceeding Nevada's 2-nanogram legal limit. Charges included two felony B counts — felony DUI resulting in death and felony child neglect — carrying a potential 16–20 year prison sentence. Jeff accepted an Alford plea to felony reckless driving and misdemeanor DUI; the judge acknowledged he was not impaired but stated the law left her no choice. Probation terms banned cannabis use, forcing Jeff back onto 22 pills daily — highlighting the legal contradiction that allows high-dose opioid use while prohibiting medical cannabis. Nevada's 2-nanogram THC limit dates to 1999 and is based on a 1986–87 study measuring residual THC in reckless drivers' urine — not impairment — making it scientifically unsound. THC can remain in blood for weeks in chronic users, and up to 90 days depending on testing method and consumption type, meaning the legal limit bears no relationship to actual impairment. Other states apply higher or more flexible standards — California, Washington, and Colorado allow 5 nanograms with rebuttal options, and Michigan does not prosecute medical patients — contrasting sharply with Nevada's near-zero-tolerance approach. Jeff advocates for impairment-based DUI laws rather than residual THC thresholds, arguing that trained Drug Recognition Experts can assess actual impairment without relying on metabolite levels. As president of the Coalition for Patient Rights, Jeff is pushing for federal cannabis de-scheduling — arguing Schedule 3 is insufficient — and working with NORML, MPP, and other organizations to advance legislative reform. Visit our website: CannabisHealthRadio.comDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

  State lawmakers are headed back up to Utah's Capitol Hill this week for the first interim session since the legislative general session ended in March. Among the things being discussed tonight is medical cannabis here in Utah. You'll recall that the federal government changed the scheduling for state-issued medical marijuana last month, and now the state has to look at its own laws to see how things will change here.  

Can medical cannabis care become more personalized and patient-focused? Trevor and Kirk talk with Seann Poli of JANrx about raising capital during the early LP boom to building a 100% Canadian, independent medical cannabis company.Seann tells us about veteran cannabis care, challenges dealing with insurance companies, CBD/CBN products, medical cannabis education, and the future of holistic cannabinoid wellness in Canada.Learn how personalized cannabis support is helping veterans manage PTSD, sleep, pain, and overall health for veterans and civilians alike.Seann Poli - LinkedInJANrx -WebsiteTranscripts, papers and so much more at: reefermed.ca

It's Monday, May 18. Here are today's top stories around Central Indiana. Want to go deeper on the stories you hear on WFYI News Now? Visit wfyi.org and follow us on social media to get local news every day. WFYI News Now is hosted by Barb Anguiano and produced by Zach Bundy. Subscribe wherever you get your podcasts.

Boy howdy do we have something to talk about with our favorite medical cannabis subject matter expert today! On April 23, 2026, the U.S. Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) signed an order reclassifying (rescheduling) state-licensed medical marijuana and FDA-approved marijuana products from Schedule I to Schedule III of the Controlled Substances Act). Let's get into it with Dr. Mikhail “Misha” Kogan, chief medical officer of the GW Center for Integrative Medicine, associate professor of Medicine at the GW School of Medicine & Health Sciences, and author of the highly acclaimed book “Medical Marijuana: Dr. Kogan's Evidence-Based Guide to the Health Benefits of Cannabis and CBD.” Along with being an internationally recognized expert on medicinal cannabis, Dr. Kogan has extensive training and expertise in internal medicine, geriatrics, palliative care, social and primary care medicine, integrative medicine, herbal medicine, and craniosacral therapy. He specializes in diagnosing and developing treatment plans for the most complex health challenges, offering hope to even the most desperate patients. His specific area of interest is utilizing cannabis as a solution to reduce polypharmacy in the geriatric patient population. He is a renowned international speaker in the field of medical cannabis. ◘ Related Links The Society of Cannabis Clinicians https://bit.ly/48xFsrR Medical Marijuana: Dr. Kogan's Evidence-Based Guide to the Health Benefits of Cannabis and CBD https://bit.ly/4tMfWI1 GW Integrative Medicine Podcast: Medical Cannabis, Psilocybin, & More Playlist https://bit.ly/4n2A325 Science Friday interviews Dr. Kogan (25 min.) https://bit.ly/429HsTE Developing Medical Cannabis Competencies: A Consensus Statement https://bit.ly/4cN9wlK ◘ Transcript bit.ly/3JoA2mz ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

https://vimeo.com/1186533175?share=copy&fl=sv&fe=ci https://www.currentfederaltaxdevelopments.com/podcasts/2026/4/25/2026-04-27-no-more-280e-for-state-legal-medical-cannabis-businesses This week we look at: Tax Implications of the Rescheduling of State-Licensed Medical Marijuana Disallowance of COVID-19 Leave Credits: A Review of Substantiation and Trade or Business Requirements Substantiation, Entity Indebtedness, and Business Expense Deductibility: An Analysis of the Simmons Case The Tenth Circuit Codifies the Reach of the Economic Substance Doctrine Over Mechanical Statutory Compliance Treatment of Loyalty Rewards Program Funds and the Claim of Right Doctrine Valuation and Penalty Controversies in Estate Tax Examinations

The Trump Administration is changing federal cannabis policy. On Thursday acting Attorney General Todd Blanche signed an order reclassifying medical marijuana from a Schedule I to a Schedule III drug. That puts the drug in the same category as substances like ketamine and anabolic steroids. Now, this doesn’t mean cannabis is legal nationwide, and people with convictions related to marijuana won’t see their charges dropped. But officials say it’ll allow for more research into cannabis for medical use. For distributors in the 40 states that have medical marijuana systems already in place, it could mean tax benefits and less hoops to jump through when selling cannabis. This reclassification does not impact recreational marijuana. But advocates say it could be a sign of bigger changes to come. Guest: Dr. Susan Ferguson, Director of the Addictions, Drug & Alcohol Institute at the University of Washington Related links: Justice Department Places FDA-Approved Marijuana Products and Products Containing Marijuana Subject to a Qualifying State-issued License in Schedule III, Strengthening Medical Research While Maintaining Strict Federal Controls Federal Marijuana Rescheduling Will End Discrimination In Housing, Healthcare And Employment For Medical Cannabis Patients (Op-Ed) - Marijuana Moment SAM CONDEMNS IN THE STRONGEST POSSIBLE TERMS THE TRUMP ADMINISTRATION’S ILLEGAL DIRECTIVE ON MARIJUANA RESCHEDULING - Smart Approaches to Marijuana Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

DEA rescthedules state-legal medical marijuana, but recreational cannabis stays on Schedule III (and 280E issues continue for those businesses), Seventh Circuit finds claim of right can be used to exclude income from taxation and more.

This week we look at: Tax Implications of the Rescheduling of State-Licensed Medical Marijuana Disallowance of COVID-19 Leave Credits: A Review of Substantiation and Trade or Business Requirements The Tenth Circuit Codifies the Reach of the Economic Substance Doctrine Over Mechanical Statutory Compliance Substantiation, Entity Indebtedness, and Business Expense Deductibility: An Analysis of the Simmons Case Treatment of Loyalty Rewards Program Funds and the Claim of Right Doctrine Valuation and Penalty Controversies in Estate Tax Examinations

Dr. Hemant Kumar Bid is a top educator in the field of Biotechnology and Medical cannabis. He serves as Program Director for the Morehouse School of Medicine, using his extensive background in biotechnology research and cannabinoid research to educate graduate students and infuse the industry with science-backed legitimacy. Recently, Hemant has become deeply engaged with Artificial Intelligence and Machine Learning through his academic, clinical, and program development work.  During our conversation we discuss: How AI and machine learning are accelerating drug discovery, enabling personalized treatment, and analyzing complex genomic and clinical data. How the Morehouse School of Medicine is updating its biotechnology curriculum to integrate AI/ML  Why the accuracy of AI predictions depends entirely on data quality fed into the models, making standardization, diverse representation, and clean datasets critical for success How AI can help reduce trial-and-error prescribing in favor of personalized care for specific patient conditions, optimized dosing, and potential adverse effects and/or drug interactions. Major challenges that need to be overcome before AI and ML can truely transform medical cannabis treatment.  Thanks to This Episode’s Sponsor: Tikun Olam Tikun Olam is the world’s first licensed medical cannabis company. With over 20 years of clinical cannabis research, Tikun Olam has conducted 7 clinical trials and published over two dozen academic journal studies using its heirloom cultivars. Tikun Olam products are designed for specific needs: pain relief, better sleep, digestive comfort, and neurological balance — all standardized for consistent, predictable results. If you’re curious to learn more about their products or research, they even offer a free one-on-one consultation with a licensed nurse. Shop online or find a dispensary at tikunolam.com Additional Resources Register for CannMed 26 Meet the CannMed 26 Speakers Review the Podcast

"We are not going after the high. What we're going for is symptom relief. Based on our research, employers are going to be saving $5,000 per participant per year."Is it time for employers to start covering medical cannabis?My guest this week is Emily Fisher, Founder of LeafWell. As a stage 4 breast cancer patient, Emily experienced firsthand the therapeutic benefits of cannabis when traditional opioid painkillers failed her. However, she also experienced the frustration of navigating the dispensary system without any clinical guidance or oversight.She founded LeafWell to solve this problem by connecting patients with licensed healthcare providers via telehealth to receive personalized, clinically-guided cannabis care plans. Now, LeafWell has served over 500,000 patients and is bringing their platform directly to self-funded employers.In this episode, we tackle the stigma and misconceptions surrounding medical cannabis in the workplace. Emily explains how LeafWell differentiates between "presence and impairment," the strict guardrails they use for safety-sensitive jobs, and why clinically-guided cannabis therapy is helping patients reduce or eliminate highly addictive opioids and expensive pharmaceuticals.If you are an employer or a benefits consultant looking for an innovative, holistic approach to managing chronic pain and reducing pharmacy spend, this conversation will completely change how you view cannabis as an employee benefit.Thank you to our 2026 sponsors!ParetoHealth: ParetoHealth empowers midsize employers with a long-term solution to reduce volatility and lower overall health benefits costs. Visit https://www.paretohealth.com/fully-insured-vs-self-funding-with-paretohealth-spencer-podcast/?utm_source=youtube&utm_medium=referral&utm_campaign=SelfFundedwSpencer to learn more.Samaritan Fund: A program that connects those who need help to the support they need. We are proud to offer the Samaritan Fund Program. Visit SamaritanFundProgram.com to learn more.Vālenz Health: We're Vālenz Health, your partner in improving health literacy, reducing plan spend, and delivering high-value healthcare. Visit ValenzHealth.com to learn more.Imagine360: Imagine360 helps self-funded employers save on healthcare with smarter health plans. Cut expenses by 20-30% with custom solutions. Contact us today at Imagine360.com.Chapters:(00:00:00) Intro: Medical Cannabis as an Employee Benefit? (00:04:05) Emily's Story: Surviving Stage 4 Breast Cancer (00:08:25) Launching LeafWell: Increasing Access, Education, & Research (00:11:55) Dispensary "Bud Tenders" vs. Clinically Guided Care (00:15:24) Why Cannabis is a $29 Billion Healthcare Savings Opportunity (00:18:01) Reducing Prescription Drugs & Avoiding the ER (00:21:15) Addressing the Elephant in the Room: Impairment at Work (00:26:32) Differentiating Between Presence (Urine Tests) and Impairment (00:29:29) Form Factors: Tinctures, Capsules, and Avoiding Inhalables (00:35:47) How the Endocannabinoid System Works (00:42:00) The Future: Will the Government Reschedule Cannabis? (00:46:54) How Employers Can Roll Out a Medical Cannabis ProgramKey Links for Social:@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFundedListen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/

"We are not going after the high. What we're going for is symptom relief. Based on our research, employers are going to be saving $5,000 per participant per year."Is it time for employers to start covering medical cannabis?My guest this week is Emily Fisher, Founder of LeafWell. As a stage 4 breast cancer patient, Emily experienced firsthand the therapeutic benefits of cannabis when traditional opioid painkillers failed her. However, she also experienced the frustration of navigating the dispensary system without any clinical guidance or oversight.She founded LeafWell to solve this problem by connecting patients with licensed healthcare providers via telehealth to receive personalized, clinically-guided cannabis care plans. Now, LeafWell has served over 500,000 patients and is bringing their platform directly to self-funded employers.In this episode, we tackle the stigma and misconceptions surrounding medical cannabis in the workplace. Emily explains how LeafWell differentiates between "presence and impairment," the strict guardrails they use for safety-sensitive jobs, and why clinically-guided cannabis therapy is helping patients reduce or eliminate highly addictive opioids and expensive pharmaceuticals.If you are an employer or a benefits consultant looking for an innovative, holistic approach to managing chronic pain and reducing pharmacy spend, this conversation will completely change how you view cannabis as an employee benefit.Thank you to our 2026 sponsors!ParetoHealth: ParetoHealth empowers midsize employers with a long-term solution to reduce volatility and lower overall health benefits costs. Visit https://www.paretohealth.com/fully-insured-vs-self-funding-with-paretohealth-spencer-podcast/?utm_source=youtube&utm_medium=referral&utm_campaign=SelfFundedwSpencer to learn more.Samaritan Fund: A program that connects those who need help to the support they need. We are proud to offer the Samaritan Fund Program. Visit SamaritanFundProgram.com to learn more.Vālenz Health: We're Vālenz Health, your partner in improving health literacy, reducing plan spend, and delivering high-value healthcare. Visit ValenzHealth.com to learn more.Imagine360: Imagine360 helps self-funded employers save on healthcare with smarter health plans. Cut expenses by 20-30% with custom solutions. Contact us today at Imagine360.com.Chapters:(00:00:00) Intro: Medical Cannabis as an Employee Benefit? (00:04:05) Emily's Story: Surviving Stage 4 Breast Cancer (00:08:25) Launching LeafWell: Increasing Access, Education, & Research (00:11:55) Dispensary "Bud Tenders" vs. Clinically Guided Care (00:15:24) Why Cannabis is a $29 Billion Healthcare Savings Opportunity (00:18:01) Reducing Prescription Drugs & Avoiding the ER (00:21:15) Addressing the Elephant in the Room: Impairment at Work (00:26:32) Differentiating Between Presence (Urine Tests) and Impairment (00:29:29) Form Factors: Tinctures, Capsules, and Avoiding Inhalables (00:35:47) How the Endocannabinoid System Works (00:42:00) The Future: Will the Government Reschedule Cannabis? (00:46:54) How Employers Can Roll Out a Medical Cannabis ProgramKey Links for Social:@SelfFunded on YouTube for video versions of the podcast and much more - https://www.youtube.com/@SelfFundedListen/watch on Spotify - https://open.spotify.com/show/1TjmrMrkIj0qSmlwAIevKA?si=068a389925474f02Listen on Apple Podcasts - https://podcasts.apple.com/us/podcast/self-funded-with-spencer/id1566182286Follow Spencer on LinkedIn - https://www.linkedin.com/in/spencer-smith-self-funded/Follow Spencer on Instagram - https://www.instagram.com/selffundedwithspencer/

Based on data from 2023-24, roughly 23% of New Yorkers aged 21 or older reported cannabis use in the past 12 months. Although men generally have a higher prevalence of use than women, recent studies show a narrowing gap as female consumption rises. Despite this trend, research is sorely lacking on the impact of cannabis use on pregnancy, birth outcomes and overall health. Many advisory panels and organizations advise against the use of cannabis during pregnancy, but there are numerous reasons pregnant people choose to use. On today's episode, we'll talk through the evidence and provide best practices for caring for pregnant persons who use cannabis.  Related Content:  New York State Department of Health Clinical Guidelines Program Therapeutic Use of Medical Cannabis in New York State (October 2025): https://www.suguidelinesnys.org/guideline/med-cannabis/?mytab=tab_6/#pregnancy New York State Department of Health Office of Cannabis Management Cannabis Considerations for Pregnant and Breastfeeding/Chest Feeding Individuals (2022): https://cannabis.ny.gov/system/files/documents/2022/07/cannabis-considerations-for-pregnant-and-breastfeeding-chestfeeding-individuals-fact-sheet_v2.pdf New York State Behavioral Risk Factor Surveillance System Brief (November 2024-05): https://www.health.ny.gov/statistics/brfss/reports/docs/2024-05_brfss_cannabis_use.pdf New York State Office of Cannabis Management Cannabis Education Library: https://cannabis.ny.gov/education Zolotov Y, Mendoza Temple L, Isralowitz R, et al. Developing Medical Cannabis Competencies: A Consensus Statement. JAMA Netw Open. 2025;8(10):e2535049. doi:10.1001/jamanetworkopen.2025.35049 Raz M, Gupta-Kagan J, & Asnes A. THC Ingestions and Child Protective Services: Guidelines for Practitioners. J Addict Med. 2025 July-Aug;19(4):350-52. doi:10/1097/ADM.0000000000001441 Data to Action: Cannabis consumption during the perinatal period and clinicians' screening and advising, New York State outside of New York City, 2017-2018 and 2021-2022: https://apps.health.ny.gov/public/tabvis/PHIG_Public/prams/publications/Cannabis_consumption_during_the_perinatal_period.pdf Project CBD: http://projectcbd.com/ American College of Gynecologists and Obstetrics Clinical Consensus on Cannabis Use during Pregnancy and Lactation (October 2025): https://www.acog.org/clinical/clinical-guidance/clinical-consensus/articles/2025/10/cannabis-use-during-pregnancy-and-lactation CEI Training, Clinical Approaches to Medical Cannabis: https://ceitraining.org/courses/1589 CEI Clinical Consultation Line 1-866-637-2342 A toll-free service for NYS clinicians offering real-time clinical consultations with specialists on HIV, sexual health, hepatitis C, and drug user health. https://ceitraining.org/  

In this episode of The Ganjapreneur Podcast, host TG Branfalt speaks with Dr. Gil Fanciullo, a longtime physician specializing in pain management and palliative care, about his early experiences recommending cannabis to patients well before it was legally accepted. Drawing from decades in medicine, including his work at Dartmouth-Hitchcock Medical Center, Fanciullo reflects on the risks physicians once faced, the patient-driven origins of medical cannabis adoption, and how attitudes within the medical community have evolved over time. This interview explores the gaps that still exist in cannabis research, the complexities of cannabinoids and the so-called “entourage effect,” and the role cannabis could play in reducing reliance on pharmaceuticals like opioids. Fanciullo also discusses physician education, regulatory barriers, and what federal rescheduling could mean for both medical practice and the broader cannabis industry.

What's your grow question?The weirdest “secondhand high” isn't smoke drifting across a room, it's the aftershock of telling someone you love that cannabis is part of your life. When a friend, parent, partner, or co-parent finds out you use cannabis or make edibles at home, the hardest part often isn't dosing or infusion, it's finding words that don't trigger fear, shame, or a fight.I walk through why these conversations can feel so loaded: cultural residue from prohibition, the one-sided “experience gap,” and the added pressure when cannabis is still illegal where someone lives. Rather than defaulting to “it's legal” or sounding like you're building a courtroom defense, I focus on bridge-building language that starts with the relationship. You'll hear a simple framework for picking the right moment, getting clear on what you want (validation, permission, transparency), and deciding what's up for negotiation.Find the Cannabis Conversations Card on the episode page. If you're trying to live without compartmentalizing, this is a grounded guide for having the talk and then following through afterward. What's the toughest reaction you've gotten when you brought up cannabis?Join the Grower's Ask Me Anything on Thursday, April 2nd, 8pm EST. Now being streamed on YouTube! Send questions in advance to stayhigh@bitemepodcast.com!Support the show Visit the website for full show notes, free dosing calculator, recipes and more. 

Send us Fan MailThe most convincing health claims are the ones that feel personal, and few topics are as personal as medical cannabis for mental health. We take on a huge Lancet meta-analysis that pulled together 54 trials and thousands of participants to ask a simple question: does medical cannabis actually help anxiety, depression, and PTSD more than placebo? The answer is uncomfortable, especially given how common “medical marijuana for mental health” has become, and we walk through what the evidence says, where the risks may be, and why this can lead to hard but necessary conversations between patients and doctors. Then we shift to pet science based on listener requests and break down diabetes in dogs in plain language. We cover what canine diabetes mellitus is, what causes it, which dog breeds may be higher risk, and the classic symptoms owners report like increased thirst, frequent urination, increased appetite, and weight loss. We also flag diabetic ketoacidosis as an emergency, explain how diagnosis works through blood and urine testing, and outline what treatment often looks like with insulin, diet, exercise, and routine vet checkups. If you learn something, subscribe, share the episode with a friend, and leave a review so more science and pet lovers can find the show.Our LinksAll our social links are here!Support the showFor Science, Empathy, and Cuteness!Being Kind is a Superpower.All our social links are here!

Where are you listening from?A kid goes from hospice care to riding bikes again, and suddenly the cannabis conversation stops being theoretical. We sit down with Sasha, Executive Director of Realm of Caring, to unpack how that kind of outcome sparked a nonprofit that now helps tens of thousands of people navigate cannabinoid therapy with less fear and more facts.We talk about what “taking the confusion out of cannabis” actually looks like when you're a patient, a parent, or a caregiver. Sasha explains the biggest misconceptions she still runs into, why cannabis stigma stays so loud, and how Realm of Caring creates a safe place for basic questions and high-stakes decisions. You'll hear how their free one-on-one support works, what to look for in safer products (yes, certificates of analysis), and why tracking small changes like sleep, anxiety, or daily function can be more useful than chasing instant “miracle” results.We also dig into cannabis research and why scientific validation matters, including Realm of Caring's partnership with Johns Hopkins University and the value of long-term real-world data on commercially available products. One of the most powerful takeaways: improved outcomes can reduce caregiver burden, strengthening the whole family, not just the person using CBD, THC, CBG, or other cannabinoids. We close with concrete ways to help, from joining research (including options for non-users as controls) to donating monthly and sharing resources. Visit RealmofCaring.org and Podcasthon.orgSubscribe for more conversations like this, share the episode with someone who needs a trustworthy cannabis education resource, and leave a review so more listeners can find it.Join the FREE Grow Your Knowledge Challenge in the Bite Me Cannabis Club and join the Grower's Ask Me Anythingon Thursday, April 2nd, 8pm EST. LINK HERE. Find the Fresh Start Complete 30 Tolerance Break Guide on Amazon in paperback or Kindle and do a t-break when you're ready! Science shows even a short break can be helpful!Support the show Visit the website for full show notes, free dosing calculator, recipes and more. 

In this episode of MiCannaCast, we sit down with Jake Greba— founder of Midnight Roots, longtime legacy cultivator, edible pioneer, and music producer Bass Owl — for a deep, wide-ranging conversation about cannabis culture, genetics, medicine, creativity, and the journey from underground roots to the modern legal market.Jake shares powerful personal stories about growing up in a cannabis family, using the plant to help loved ones through serious medical conditions, navigating the pre-legal era, and building a respected brand rooted in authenticity rather than hype.We also dive into strain selection philosophy, terpene appreciation, why THC percentage doesn't equal quality, the dilution of genetics in today's market, and how cannabis connects to memory, ritual, and community.Beyond cannabis, the conversation explores Jake's parallel life in music — touring, producing bass music, and the creative mindset that links art and cultivation.If you care about legacy cannabis culture, real genetics, meaningful consumption, or the intersection of creativity and plant medicine, this episode delivers one of the deepest conversations we've had on the show.

This week on the The Armor Men's Health Show, Donna Lee welcomes Stephen Macenas, a Physician Associate with Urology Specialists of Austin, to answer an important listener question:“Are there holistic options for treating erectile dysfunction?”Stephen walks us through how providers take a whole-body approach when evaluating ED. That includes looking at blood flow, lifestyle habits, supplements, smoking status, sleep quality, nutrition, and overall cardiovascular health. He explains how these factors play a key role in the holistic urology care provided by the team.One supplement often recommended to support healthy blood flow is Arterosil, a cardiovascular supplement that many of the practice's providers consider a strong starting point when exploring supplement-based ED support. Stephen also discusses several other supplement options that may help improve circulation and vascular health.Later in the episode, Stephen shares details about his newest passion project: Green Dreams Health, a medical cannabis practice based in Austin. Through Green Dreams Health, patients can receive an evaluation and, if appropriate, a prescription for medical cannabis that is dispensed through Texas Original, the state's licensed provider.Stephen also talks about recent updates from Greg Abbott, which have expanded access to medical cannabis for Texans who may benefit from it.You might be surprised to hear a urology practice discuss medical cannabis, but Stephen explains why many patients may qualify — including those living with chronic pain, cancer, and other qualifying conditions.Learn more about Green Dreams Health at https://greendreamshealth.com, where you can schedule a free telemedicine consultation with Stephen.For more information about the show and men's health resources, visit https://armormenshealth.com. You can also submit a question there for the team to answer anonymously on a future episode.If you enjoyed this episode, please share the podcast with a friend and help spread the word about men's health!

Send a textOn the latest episode of The Cannabis Conversation, our host, Anuj Desai, speaks with Thomas Gray & Nikita Cretu, the co-founders of Lumino, Europe's leading recruitment agency for the legal cannabis industry.We explore the history of the podcast, delve a little bit into Anuj's story, and share the big news on the podcast's future going forward.❇️ Get in touch at https://www.thecannabisconversation.euConnect with Thomas Gray on LinkedIn:  /thomas-c-s-gray Connect with Nikita Cretu on LinkedIn:  /nikita-cretu-b24b83a8 ---You can also listen in via:

Welcome to Episode 295 of Autism Parenting Secrets.This week, we shine a light on one of the most misunderstood and often controversial therapies in the autism world: medical cannabis.My guest is Dr. David Berger, known to many simply as Dr. David.He's a board-certified pediatrician with over 25 years of clinical experience.He's the founder of Wholistic Pediatrics & Family Care in Tampa, Florida, where he helps children and adults address root causes behind challenges like autism, ADHD, and immune dysfunction.He's also the founder of Wholistic ReLeaf, Florida's first pediatric medical cannabis clinic, where he's guided countless families in using cannabis-based therapies safely, responsibly, and with clear medical oversight.Dr. David brings both compassion and clarity to this conversation, helping parents understand how cannabis can support calm, focus, and balance when used appropriately as part of a broader, integrative approach.We dive into the science, the misconceptions, and the real-world application of using cannabis as medicine, along with what every parent should understand before considering this option.The secret this week is… Cannabis Is Medicine - If You Know How To Use ItYou'll Discover:How A Personal Family Experience With CBD Sparked Dr. Berger's Clinical Use Of Cannabis (2:12)What Every Parent Should Understand About The Endocannabinoid System And Why It Matters (9:00)How Different Cannabinoids (CBD, CBG, CBN, THC) Serve Very Different Therapeutic Purposes (11:42)The Research Showing Endocannabinoid Deficiency In Children With Autism (14:39)Why Many Children Respond Quickly And How To Introduce Cannabis Safely And Responsibly (18:58)About Our Guest:Dr. David Berger is a board-certified pediatrician with over 25 years of clinical experience and a national reputation for his integrative approach to family and pediatric care.  He is the founder of Wholistic Pediatrics & Family Care and Wholistic ReLeaf, Florida's first pediatric medical cannabis clinic. His practice specializes in autism, ADHD, allergies, immune dysfunction, and chronic complex conditions, combining nutritional, lifestyle, and biomedical therapies to address root causes.  A leading voice in the responsible use of medical cannabis for children, Dr. Berger is one of only a few pediatricians in Florida qualified to certify patients under the age of 18. He has also advised the FDA on vaccine safety and launched DrDavidMD, a media and education platform focused on health, education, and medical choice.wholisticfamilycare.comdrdavidmd.comReferences In This Episode:Dr. David's YouTube ChannelP2I HealthAdditional Resources:To learn more about personalized 1:1 support go to www.elevatehowyounavigate.comTake The Quiz: What's YOUR Top Autism Parenting Blindspot?If you enjoyed this episode, share it with your friends.

There's more to cannabis than people realise. In this episode of Everything Is Personal, Angie Roullier shares her journey living with Charcot-Marie-Tooth disease (CMT), a hereditary neurological nerve disorder that causes progressive nerve damage, muscle weakness, and related symptoms, navigating a broken healthcare system, and discovering how the endocannabinoid system and plant medicine transformed her quality of life. From pharmaceutical dependency and kidney complications to education, advocacy, and whole-plant medicine — this conversation dives deep into: • Medical cannabis education • The endocannabinoid system explained • Autoimmune triggers & inflammation • Why THC and CBD work differently • Healthcare system failures • Cannabis stigma & rescheduling debate • Medical vs recreational cannabis If you want to understand how cannabis as medicine actually works — beyond the headlines — this episode is essential. EndoDNA: Where Genetic Science Meets Actionable Patient Care EndoDNA bridges the gap between complex genomics and patient wellness. Our patented DNA analysis platforms and AI technology provide genetic insights that support and enhance your clinical expertise. Click here to check out to take control over your Personal Health & Wellness   Connect with EndoDNA on SOCIAL: IG | X | YOUTUBE | FB Connect with host, Len May, on IG     Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.